Alzinova improves manufacturing process of ALZ-101 to meet phase 2 requirements
/PRNewswire/ -- Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing disease-modifying treatments for Alzheimer's, today announces that the...
Source: prnewswire.com